At 12 weeks post-implantation, the amplitude of the compound muscle action potential (CMAP) recorded from the implanted constructs containing the neurotrophic factor-loaded microspheres (the MSs cohort) showed a trend to be higher than that in the Control and NFs cohorts.
← all excerpts
Accelerated innervation of biofabricated skeletal muscle implants containing a neurotrophic factor delivery system.
1
—
—